NCT02401464View on ClinicalTrials.gov

A Bioequivalence Study of TAK-536 Pediatric Formulation

PHASE1CompletedINTERVENTIONAL

Enrollment

52

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions

Japanese Healthy Adult Males

Interventions

DRUG

TAK-536 Tablet

TAK-536 10 mg tablet

DRUG

TAK-536 Dry Syrup Formulation

TAK-536 dry syrup formulation

DRUG

TAK-536 Ganule Formulation

TAK-536 granule formulation

Trial Locations (1)

Unknown

Kagoshima

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY